Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 6 Sarcoma 3 Melanoma 2 Leiomyosarcoma 2 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Melanoma, Cutaneous Malignant 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hyperthermia 1 Advanced Melanoma 1

Interventions

Diathermy 10 Radiotherapy 6 Surgical Procedures, Operative 2 Solutions 2 Hyperthermia, Induced 2 Hydrogen Peroxide 2 Drug Therapy 2 Brachytherapy 2 tislelizumab 1 anlotinib 1 Temozolomide 1 Saline Solution 1 Radiation 1 Patient Reported Outcome Measures 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Folfox protocol 1 Fluorouracil 1 Doxorubicin 1 Dacarbazine 1 Consolidation Chemotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hyperthermia × Dacarbazine × Clear all

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡